仟源医药：2024年净利润4219.01万元，同比增长67.45%

Core Viewpoint - QianYuan Pharmaceutical (300254) reported a revenue of 847 million yuan for 2024, reflecting a year-on-year growth of 5.92% [1] - The net profit attributable to shareholders of the listed company was 42.19 million yuan, showing a significant year-on-year increase of 67.45% [1] - The company announced plans not to distribute cash dividends, issue bonus shares, or increase share capital from reserves [1] Financial Performance - Revenue for 2024 reached 847 million yuan, up 5.92% compared to the previous year [1] - Net profit attributable to shareholders was 42.19 million yuan, marking a 67.45% increase year-on-year [1] Dividend Policy - The company will not distribute cash dividends [1] - No bonus shares will be issued [1] - There will be no increase in share capital from reserves [1]